AI-Powered Risk Triaging Is Changing How We Detect Disease, Delivering Early Insights to Millions
Remidio is redefining preventive healthcare through AI-powered oculomics, shifting the focus from mass screening to intelligent risk triaging. By enabling early detection of chronic eye and systemic diseases at the last mile, its portable retinal diagnostics have reached over 16 million people globally—reducing costs, improving access, and ensuring timely care for those most at risk.
Share
Sector
Solution
Technology
State of Origin
Impact Metrics
16M+ people
risk-triaged across 55 countries.
450+ centres
for primary, secondary, and tertiary health across India, expanding last-mile access to preventive care.
~85% reduction
in screening costs, lowering per-patient costs from ₹4,000–5,000 to ~₹400 in public health programs.
1.2M+ retinal scans
analyzed, generating large-scale epidemiological insights including glaucoma prevalence (2.3%–6%).
Resources to Replicate This Idea
BUILD YOUR OWN
Do you want to know how this innovator scaled their idea, how much it cost them, and what resources/partnerships they deployed?
Handpicked stories tailored just for you
Explore stories that inspire, inform, and ignite new ideas across tech, innovation, and real-world impact
